Middleton & CO Inc Abb Vie Inc. Transaction History

Middleton & CO Inc

$898 Million
Q3 2024

A detailed history of Middleton & CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Middleton & CO Inc holds 86,979 shares of ABBV stock, worth $17.4 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

86,979

Previous 87,643 0.76%

Holding current value

$17.4 Million

Previous $15 Million 14.26%

% of portfolio

1.91%

Previous 1.75%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$163.84 - $199.33 $108,789 - $132,355	-664 Reduced 0.76%	86,979 $17.2 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $271,656 - $317,233	-1,755 Reduced 1.96%	87,643 $15 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $132,650 - $151,143	-830 Reduced 0.92%	89,398 $16.3 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $120,950 - $136,218	-879 Reduced 0.96%	90,228 $14 Million
Q3 2023 Oct 26, 2023	SELL	$133.59 - $154.65 $101,929 - $117,997	-763 Reduced 0.83%	91,107 $13.6 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $1.19 Million - $1.48 Million	-8,981 Reduced 8.91%	91,870 $12.4 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $196,524 - $226,327	-1,359 Reduced 1.33%	100,851 $16.1 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $7,468 - $8,956	54 Added 0.05%	102,210 $16.5 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $464,500 - $532,751	-3,461 Reduced 3.28%	102,156 $13.7 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $1.52 Million - $1.94 Million	-11,081 Reduced 9.5%	105,617 $16.2 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $986,682 - $1.22 Million	-7,476 Reduced 6.02%	116,698 $18.9 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $32,766 - $41,458	-305 Reduced 0.25%	124,174 $16.8 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 0.08%	124,479 $13.4 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $1.11 Million - $1.24 Million	-10,553 Reduced 7.82%	124,379 $14 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $294,828 - $324,570	2,882 Added 2.18%	135,217 $15.1 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $29,155 - $32,096	-285 Reduced 0.21%	134,932 $14.6 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $14,085 - $19,017	175 Added 0.13%	132,335 $14.2 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $46,735 - $54,851	544 Added 0.41%	132,160 $11.6 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $233,683 - $312,703	3,185 Added 2.48%	131,616 $12.9 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $117,841 - $178,662	-1,827 Reduced 1.4%	128,431 $9.79 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $332,230 - $415,691	-4,606 Reduced 3.42%	130,258 $11.5 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $168,093 - $202,096	-2,669 Reduced 1.94%	134,864 $10.2 Million
Q2 2019 Jul 25, 2019	SELL	$65.7 - $83.98 $115,500 - $147,636	-1,758 Reduced 1.26%	137,533 $10 Million
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $140,471 - $165,328	1,821 Added 1.32%	139,291 $11.2 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $422,647 - $521,238	-5,429 Reduced 3.8%	137,470 $12.7 Million
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $485,715 - $539,962	5,463 Added 3.97%	142,899 $13.5 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $113,571 - $134,380	1,265 Added 0.93%	137,436 $12.7 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $1.31 Million - $1.76 Million	-14,286 Reduced 9.5%	136,171 $12.9 Million
Q4 2017 Jan 25, 2018	BUY	$89.56 - $98.21 $903,302 - $990,546	10,086 Added 7.19%	150,457 $14.6 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $9.8 Million - $12.5 Million	140,371	140,371 $12.5 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.

Account